Diabetes complications and screening

On this page

Screening & Diagnosis - Catching the Culprit

  • Screening: Asymptomatic adults aged ≥35. Any age if BMI ≥25 (≥23 in Asians) + ≥1 risk factor (e.g., family hx, HTN, PCOS).
  • Diagnostic Criteria (confirm with repeat test):
    • HbA1c: ≥6.5%
    • Fasting Plasma Glucose (FPG): ≥126 mg/dL
    • 2-hr Oral Glucose Tolerance Test (OGTT): ≥200 mg/dL
    • Random Plasma Glucose: ≥200 mg/dL + symptoms

⭐ HbA1c is unreliable in hemoglobinopathies or conditions with high RBC turnover (e.g., CKD, hemolysis); use FPG or OGTT instead.

FPG thresholds for normal, prediabetes, and diabetes

Microvascular Mayhem - Small Vessels, Big Trouble

  • Pathophysiology: Chronic hyperglycemia → advanced glycation end-products (AGEs) & polyol pathway activation → basement membrane thickening, endothelial damage, and oxidative stress.

  • Diabetic Retinopathy

    • Non-proliferative: Microaneurysms, dot-blot hemorrhages, hard exudates, cotton-wool spots.
    • Proliferative: Neovascularization (VEGF-driven), vitreous hemorrhage, retinal detachment.
    • Screening: Annual dilated fundoscopy starting 5 years post-diagnosis for T1DM, and at diagnosis for T2DM.
  • Diabetic Nephropathy

    • Earliest sign: Thickening of the glomerular basement membrane. First clinical sign is microalbuminuria.
    • Screening: Annual urine albumin-to-creatinine ratio (UACR). UACR 30-300 mg/g indicates microalbuminuria.
    • Pathology: Kimmelstiel-Wilson nodules are pathognomonic.
  • Diabetic Neuropathy

    • Peripheral: Distal, symmetric "stocking-glove" polyneuropathy. Loss of proprioception & vibration.
    • Screening: Annual comprehensive foot exam, including 10-g monofilament test.
    • Autonomic: Gastroparesis, orthostatic hypotension, erectile dysfunction.

⭐ ACE inhibitors or ARBs are first-line therapy for diabetic nephropathy, providing renal protection independent of their antihypertensive effects.

Diabetic Retinopathy Severity Levels and Hallmarks

Macrovascular Mess - The Highway to Hazard

  • Atherosclerosis is the primary pathology, accelerated by chronic hyperglycemia, insulin resistance, and dyslipidemia. Leads to major adverse cardiovascular events (MACE).
  • Coronary Artery Disease (CAD)
    • Most common cause of death in diabetics.
    • Screen with stress testing if symptomatic or high-risk.
  • Cerebrovascular Disease (CVD)
    • Leads to ↑ risk of stroke and transient ischemic attacks (TIA).
  • Peripheral Arterial Disease (PVD)
    • Presents with claudication, non-healing ulcers, and gangrene.
    • Screen with Ankle-Brachial Index (ABI) if symptomatic.

⭐ Due to diabetic autonomic neuropathy, myocardial infarctions can be "silent," presenting with atypical symptoms like shortness of breath, fatigue, or nausea instead of classic chest pain.

Diabetic Foot - An Achilles' Heel

Diabetic foot ulcer with cellulitis

  • Pathophysiology Triad:
    • Neuropathy: ↓ sensation & motor control (📌 SAD: Sensory, Autonomic, Motor).
    • Peripheral Artery Disease (PAD): ↓ blood flow, poor healing.
    • Immunocompromise: ↑ infection risk.
  • Screening (Annual):
    • Neuropathy: 10-g monofilament test.
    • Vascular: Ankle-brachial index (ABI).
  • Management:
    • Glycemic control, patient education, proper footwear.
    • Ulcer care: Debridement, dressings, offloading pressure.

Charcot foot (neuroarthropathy) is a severe complication causing bone destruction, subluxation, and foot deformity in neuropathic patients.

High‑Yield Points - ⚡ Biggest Takeaways

  • Annual screening for retinopathy, nephropathy (urine albumin/creatinine ratio), and neuropathy is crucial.
  • ACE inhibitors or ARBs are first-line for diabetic nephropathy, even with normal blood pressure.
  • Diabetic foot ulcers are a major risk; perform a comprehensive foot exam annually.
  • Painful diabetic neuropathy is commonly treated with gabapentin or pregabalin.
  • Macrovascular disease (CAD, stroke) is the leading cause of death; manage lipids and blood pressure aggressively.
  • Screen asymptomatic adults for T2DM starting at age 35.

Practice Questions: Diabetes complications and screening

Test your understanding with these related questions

A 52-year-old man presents to his primary care physician to discuss laboratory results that were obtained during his annual checkup. He has no symptoms or concerns and denies changes in eating or urination patterns. Specifically, the physician ordered a panel of metabolic laboratory tests to look for signs of diabetes, hyperlipidemia, or other chronic disorders. A spot glucose check from a random blood sample showed a glucose level of 211 mg/dL. A hemoglobin A1c level was obtained at the same time that showed a level of 6.3%. A fasting blood glucose was obtained that showed a blood glucose level of 125 mg/dL. Finally, a 2-hour glucose level was obtained after an oral glucose tolerance test that showed a glucose level of 201 mg/dL. Which of the following statements is most accurate for this patient?

1 of 5

Flashcards: Diabetes complications and screening

1/10

Type _____ diabetes mellitus is characterized by insulin deficiency

TAP TO REVEAL ANSWER

Type _____ diabetes mellitus is characterized by insulin deficiency

1

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial